Current Opinion in Organ Transplantation was launched in 1996. It is part of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of organ transplantation is divided into 18 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Section Editors for this issue.
Laurence A. Turka
Larry Turka received his MD degree from the Yale University School of Medicine, USA, and trained in internal medicine at Yale-New Haven Hospital, USA. Dr Turka was a renal fellow at the Brigham and Women's Hospital, USA, where his research fellowship was conducted in Dr Charles B. Carpenter's laboratory. In 1988, Dr Turka joined the faculty of the University of Michigan, USA, working first under the mentorship of Craig B. Thompson, MD, and then establishing his independent research program. In 1994 Dr Turka joined the faculty of the University of Pennsylvania, USA. In 1998 he was promoted to Professor and Chief of the Renal Division. In 2009 Dr Turka came to Boston as a Professor of Medicine at Harvard Medical School, USA, and is currently located at the Massachusetts General Hospital, USA, where he is Co-Director of the Transplantation Biology Research Center, and Scientific Director the Transplant Center. Dr Turka has been continuously funded by the National Institutes of Health (NIH) for the past 25 years, and has also received funding from the American Heart Association, the National Kidney Foundation, and the Juvenile Diabetes Foundation International. He received the Young Investigator Award from the American Society of Nephrology in 1996, and from the American Society of Transplantation in 1998. He is a former President of the American Society of Transplantation. He has served as a permanent member of the Surgery, Anesthesiology and Trauma (SAT) study section, and Chair of the National Institute of Allergy and Infectious Diseases (NIAID) Board of Scientific Counselors. He is a former section editor of The Journal of Immunology, past associate editor of The American Journal of Transplantation, and Editor in Chief of The Journal of Clinical Investigation. He currently serves as Deputy Director of the Immune Tolerance Network, and Co-Director of the Harvard Institute for Translational Immunology. He was elected to membership in the American Society for Clinical Investigation in 1995, and the Association of American Physicians in 2003.
Dr Turka's research is in the area of T cell immunobiology with a particular focus on T cell tolerance. He has had a long-standing research program in the field of T cell costimulation and the CD28 pathway. More recent interests include intracellular signaling and metabolic pathways which regulate T cell fate determination and regulatory T cell stability.
Xian Chang Li
Dr Xian Li is Professor of Surgery at the Methodist Hospital, USA, and Director of the Transplant Immunology Center at Methodist Hospital Research Institute in Houston Texas, USA. The Methodist Hospital is physically located at Texas Medical Center and academically affiliated with Weil Cornell Medical College of Cornell University in New York, USA. The focus of Dr Li's team is to understand the fundamental mechanisms of transplant rejection and transplant tolerance as well as how to translate such knowledge to the clinic to improve transplant outcomes.
Dr Xian Li received his medical training in China and his PhD training in immunology in Canada. He has had a productive career at Harvard Medical School, USA, before moving to the Methodist Hospital. Dr Li has published extensively in the area of transplant immunology and is recognized with many awards including the Weyth achievement award from American Society of Transplantation (AST). He is an elected member of American Society for Clinical Investigation (ASCI). He has served in several professional societies, including the Basic Science Advisory Council for the AST, the Basic Science Committee of The Transplantation Society (TTS), and Faculty 1000 for immunology. He has been a standing member of National Institutes of Health (NIH) study sections and acted as an associate editor for the Journal of Immunology.
Dr Süsal studied medicine at the University of Heidelberg, Germany, between 1980 and 1986. Since 1987, he has been working at the Department of Transplantation Immunology, University of Heidelberg where he is currently supervising the Antibody Laboratory and a research lab. His scientific interest is focused on the role of HLA and non-HLA immunity in organ transplantation, pre- and post-transplant risk estimation, transplantation of highly immunized patients and establishment of biomarkers for immune tolerance. He authored more than 120 publications and received multiple awards for his research. In 2005, he became Professor of Immunology. Currently, he is the Vice-President of the German Society for Immunogenetics, head of the Immunology Committee of the German Transplantation Society, head of the Organ Transplantation Committee of the Germany Society for Immunogenetics, member of the Eurotransplant Executive Board and, since 2009, one of the new Key Opinion Leaders (nKOLs) of The Transplantation Society.